Genpax is building a game-changing bacterial analysis platform. Using bioinformatics, we can help hospitals take early and effective action against outbreaks of MRSA and other pathogens. This is an opportunity to have a real-world impact on thousands of lives each year.
At Genpax our goal is to radically increase the utility, scalability, and speed with which whole genome sequencing (WGS) data delivers infection control solutions for human and animal healthcare worldwide. This will enable proactive control at early stages of outbreaks, and to respond appropriately to more dangerous or more antibiotic resistant strains. We have developed unique solutions to address the challenges and our goal is to provide access to these solutions in a fully scalable system.
There are really interesting engineering problems to be solved: scaling and optimising our analysis pipeline and the bioinformatics algorithms we use; building out our interactive graph-based user-facing product; developing cryptographic techniques for analysis of anonymised data. At the moment we're using Python, GraphQL, React/TypeScript, Postgres and AWS.
£45-95k + equity, based on experience.
jfreeman+hn@genpax.co